BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 2465399)

  • 1. Distinction between hepatocellular carcinoma, cholangiocarcinoma, and metastatic carcinoma based on immunohistochemical staining for carcinoembryonic antigen and for cytokeratin 19 on paraffin sections.
    Balaton AJ; Nehama-Sibony M; Gotheil C; Callard P; Baviera EE
    J Pathol; 1988 Dec; 156(4):305-10. PubMed ID: 2465399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic value of cytokeratins and carcinoembryonic antigen immunostaining in differentiating hepatocellular carcinomas from intrahepatic cholangiocarcinomas.
    Stroescu C; Herlea V; Dragnea A; Popescu I
    J Gastrointestin Liver Dis; 2006 Mar; 15(1):9-14. PubMed ID: 16680226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma versus carcinoma metastatic to the liver. Value of stains for carcinoembryonic antigen and naphthylamidase in fine needle aspiration biopsy material.
    Wong MA; Yazdi HM
    Acta Cytol; 1990; 34(2):192-6. PubMed ID: 2157322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyclonal carcinoembryonic antigen staining in the cytologic differential diagnosis of primary and metastatic hepatic malignancies.
    Wolber RA; Greene CA; Dupuis BA
    Acta Cytol; 1991; 35(2):215-20. PubMed ID: 1709323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma.
    Lau SK; Prakash S; Geller SA; Alsabeh R
    Hum Pathol; 2002 Dec; 33(12):1175-81. PubMed ID: 12514785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoplasmic staining of TTF-1 in the differential diagnosis of hepatocellular carcinoma vs cholangiocarcinoma and metastatic carcinoma of the liver.
    Lei JY; Bourne PA; diSant'Agnese PA; Huang J
    Am J Clin Pathol; 2006 Apr; 125(4):519-25. PubMed ID: 16627262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of cytokeratins 7, 19, and 20 in primary and metastatic carcinomas of the liver.
    Maeda T; Kajiyama K; Adachi E; Takenaka K; Sugimachi K; Tsuneyoshi M
    Mod Pathol; 1996 Sep; 9(9):901-9. PubMed ID: 8878022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Das-1 immunostain is useful for discriminating metastatic colon adenocarcinoma from cholangiocarcinoma and hepatocellular carcinoma.
    Zimmerman RL; Das KM; Fogt F; Burke M; Murakata LA
    Oncol Rep; 2002; 9(6):1369-72. PubMed ID: 12375050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keratin polypeptides in malignant epithelial liver tumors. Differential diagnostic and histogenetic aspects.
    Fischer HP; Altmannsberger M; Weber K; Osborn M
    Am J Pathol; 1987 Jun; 127(3):530-7. PubMed ID: 2438941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoperoxidase staining as a diagnostic aid for hepatocellular carcinoma.
    Christensen WN; Boitnott JK; Kuhajda FP
    Mod Pathol; 1989 Jan; 2(1):8-12. PubMed ID: 2466290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Necrosis in 84 ovarian carcinomas: a morphologic study of primary versus metastatic colonic carcinoma with a selective immunohistochemical analysis of cytokeratin subtypes and carcinoembryonic antigen.
    DeCostanzo DC; Elias JM; Chumas JC
    Int J Gynecol Pathol; 1997 Jul; 16(3):245-9. PubMed ID: 9421090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The utility of hepatocyte paraffin 1 antibody in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma and metastatic carcinoma.
    Shiran MS; Isa MR; Sherina MS; Rampal L; Hairuszah I; Sabariah AR
    Malays J Pathol; 2006 Dec; 28(2):87-92. PubMed ID: 18376797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma.
    Berezowski K; Stastny JF; Kornstein MJ
    Mod Pathol; 1996 Apr; 9(4):426-9. PubMed ID: 8729984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinoma.
    Röcken C; Licht J; Roessner A; Carl-McGrath S
    J Clin Pathol; 2005 Oct; 58(10):1069-75. PubMed ID: 16189153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anatomo-pathologic diagnostic interpretation of nodular hepatic lesions].
    Chiaramondia M; Ceppa P; Baccini P; Badini A; Castellaneta A
    Pathologica; 1993; 85(1100):687-99. PubMed ID: 8170717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative immunohistochemical study of primary and metastatic carcinomas of the liver.
    Ma CK; Zarbo RJ; Frierson HF; Lee MW
    Am J Clin Pathol; 1993 May; 99(5):551-7. PubMed ID: 7684185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma with mesothelioma-like dissemination.
    Otsuki Y; Shimizu S; Hosoda Y; Nagasawa M; Sato Y; Kobayashi H
    Pathol Int; 2005 Nov; 55(11):738-44. PubMed ID: 16271087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter: Alpha fetoprotein and cholangiocellular carcinoma.
    Villeneuve JP; Richer G; Côté J; Joly JG; Marleau D; Viallet A
    N Engl J Med; 1974 May; 290(22):1260. PubMed ID: 4133098
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunocytochemical localization of polyclonal carcinoembryonic antigen in hepatocellular carcinomas.
    Carrozza MJ; Calafati SA; Edmonds PR
    Acta Cytol; 1991; 35(2):221-4. PubMed ID: 1851357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokeratin patterns of liver carcinomas induced by diethylnitrosamine in monkeys.
    Lapis K; Sarosi I; Bocsi J; Thorgeirsson UP
    Lab Invest; 1995 Jun; 72(6):748-59. PubMed ID: 7540236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.